logo
Hypertonic saline: A novel therapy for advanced heart failure?
Assessing the success of fibrinolysis: Can we let the interventionalist rest?
Chronic kidney disease as a cardiovascular risk factor
Treating dyslipidemia with statins: The risk-benefit profile
Platelet activation in patients with congestive heart failure: Do we have enough evidence to consider clopidogrel?
An updated meta-analysis of calcium-channel blockers in the prevention of restenosis after coronary angioplasty
Meta-analysis of sero-epidemiologic studies of the relation between Chlamydia pneumoniae and atherosclerosis: Does study design influence results?
Preventing stroke in patients with atrial fibrillation: Current treatments and new concepts
Cardiac management by pediatricians versus pediatric cardiologists in an inpatient academic center
Effect of pacing mode on health-related quality of life in the Canadian Trial of Physiologic Pacing
Drug prescriptions after acute myocardial infarction: Dosage, compliance, and persistence
Effect of cardiac rehabilitation on functional outcomes after coronary revascularization
Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: Long-term effects
Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: The strong heart study
Ergometric score systems after myocardial infarction: Prognostic performance of the Duke Treadmill Score, Veterans Administration Medical Center Score, and of a novel score system, GISSI-2 Index, in a cohort of survivors of acute myocardial infarction
Temporal repolarization inhomogeneity and reperfusion arrhythmias in patients undergoing successful primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: Impact of admission troponin T
History of depression, angina, and quality of life after acute coronary syndromes
Two-decade-long trends (1975-1997) in the incidence, hospitalization, and long-term death rates associated with complete heart block complicating acute myocardial infarction: A community-wide perspective
A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction
Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: Results from the GUSTO-III trial
Troponin I elevation and cardiac events after percutaneous coronary intervention
Impact of renal function on morbidity and mortality after percutaneous aortocoronary saphenous vein graft intervention
Efficacy and time-efficiency of a “sonographer-driven” contrast echocardiography protocol in a high-volume echocardiography laboratory
Prognostic significance of coronary artery calcium in asymptomatic subjects with usual cardiovascular risk
Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age
Highlights from the American Heart Association Annual Scientific Sessions 2002: November 17 to 20, 2002
Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure
No effect of an L-arginine-enriched medical food (HeartBars) on endothelial function and platelet aggregation in subjects with hypercholesterolemia
Sarpogrelate treatment reduces restenosis after coronary stenting